These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28322799)

  • 1. Novel method for measurement of heparin anticoagulant activity using SPR.
    Zhao J; Liu X; Malhotra A; Li Q; Zhang F; Linhardt RJ
    Anal Biochem; 2017 Jun; 526():39-42. PubMed ID: 28322799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulant properties of heparin preparations from different animal sources with equivalent high affinity for antithrombin III.
    Nagasawa K; Uchiyama H
    J Biochem; 1984 Mar; 95(3):619-26. PubMed ID: 6725227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of Low Molecular Weight Heparin from a Remodeled Bovine Intestinal Heparin.
    Baytas SN; Varghese SS; Jin W; Yu Y; He P; Douaisi M; Zhang F; Brodfuehrer P; Xia K; Dordick JS; Linhardt RJ
    J Med Chem; 2021 Feb; 64(4):2242-2253. PubMed ID: 33586962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemometric analysis of porcine, bovine and ovine heparins.
    Ouyang Y; Han X; Yu Y; Chen J; Fu L; Zhang F; Linhardt RJ; Fareed J; Hoppensteadt D; Jeske W; Kouta A; Zhang Z; Xia K
    J Pharm Biomed Anal; 2019 Feb; 164():345-352. PubMed ID: 30428408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural Analysis of Heparin-Derived 3-O-Sulfated Tetrasaccharides: Antithrombin Binding Site Variants.
    Chen Y; Lin L; Agyekum I; Zhang X; St Ange K; Yu Y; Zhang F; Liu J; Amster IJ; Linhardt RJ
    J Pharm Sci; 2017 Apr; 106(4):973-981. PubMed ID: 28007564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural characterization of heparins from different commercial sources.
    Zhang F; Yang B; Ly M; Solakyildirim K; Xiao Z; Wang Z; Beaudet JM; Torelli AY; Dordick JS; Linhardt RJ
    Anal Bioanal Chem; 2011 Nov; 401(9):2793-803. PubMed ID: 21931955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Search for the heparin antithrombin III-binding site precursor.
    Linhardt RJ; Wang HM; Loganathan D; Bae JH
    J Biol Chem; 1992 Feb; 267(4):2380-7. PubMed ID: 1733939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal muscle myosin and cardiac myosin attenuate heparin's antithrombin-dependent anticoagulant activity.
    Morla S; Deguchi H; Griffin JH
    J Thromb Haemost; 2021 Feb; 19(2):470-477. PubMed ID: 33176060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of 3-O-sulfo group-containing heparin tetrasaccharides in heparin by liquid chromatography-mass spectrometry.
    Li G; Yang B; Li L; Zhang F; Xue C; Linhardt RJ
    Anal Biochem; 2014 Jun; 455():3-9. PubMed ID: 24680753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural characterization of pharmaceutical heparins prepared from different animal tissues.
    Fu L; Li G; Yang B; Onishi A; Li L; Sun P; Zhang F; Linhardt RJ
    J Pharm Sci; 2013 May; 102(5):1447-57. PubMed ID: 23526651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of the antithrombin-binding site in heparin.
    Lindahl U; Bäckström G; Höök M; Thunberg L; Fransson LA; Linker A
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3198-202. PubMed ID: 226960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological implications of the structural, antithrombin affinity and anticoagulant activity relationships among vertebrate heparins and heparan sulphates.
    Hovingh P; Piepkorn M; Linker A
    Biochem J; 1986 Jul; 237(2):573-81. PubMed ID: 2948492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin III affinity dependence on the anticoagulant, antiprotease, and tissue factor pathway inhibitor actions of heparins.
    Jeske W; Lormeau JC; Callas D; Iqbal O; Hoppensteadt D; Fareed J
    Semin Thromb Hemost; 1995; 21(2):193-200. PubMed ID: 7660142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limitations of conventional anticoagulant therapy and the promises of non-heparin based conformational activators of antithrombin.
    Rashid Q; Singh P; Abid M; Jairajpuri MA
    J Thromb Thrombolysis; 2012 Aug; 34(2):251-9. PubMed ID: 22453684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fractionation and structural features of two heparin families with high antithrombotic, antilipemic and anticoagulant activities.
    Bianchini P; Osima B; Parma B; Nader HB; Dietrich CP; Casu B; Torri G
    Arzneimittelforschung; 1985; 35(8):1215-9. PubMed ID: 4074437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A sensitive ELISA for the detection of bovine crude heparin in porcine heparin.
    Levieux A; Rivera V; Levieux D
    J Immunoassay Immunochem; 2001; 22(4):323-36. PubMed ID: 11816801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of chemical 6-O-sulfation of the aminodeoxyhexose residues in whale heparin with high affinity for antithrombin III to its anticoagulant properties.
    Uchiyama H; Metori A; Ogamo A; Nagasawa K
    J Biochem; 1990 Mar; 107(3):377-80. PubMed ID: 2341372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatic Generation of Highly Anticoagulant Bovine Intestinal Heparin.
    Fu L; Li K; Mori D; Hirakane M; Lin L; Grover N; Datta P; Yu Y; Zhao J; Zhang F; Yalcin M; Mousa SA; Dordick JS; Linhardt RJ
    J Med Chem; 2017 Oct; 60(20):8673-8679. PubMed ID: 28972371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo effects of low molecular weight heparins on experimental thrombosis and bleeding.
    Hirsh J
    Haemostasis; 1986; 16(2):82-6. PubMed ID: 3710297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoenzymatic synthesis of the next generation of ultralow MW heparin therapeutics.
    Masuko S; Linhardt RJ
    Future Med Chem; 2012 Mar; 4(3):289-96. PubMed ID: 22393937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.